People · Operator
Named in public records as an officer, director or promoter · active 2009–2009 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Pathogenetix, Inc. | — | Biotechnology | Series A | $23.9M | $131.6M | 2009 |
JAMES J. SAALFIELD at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside JAMES J. SAALFIELD on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Tara Butler | 1 | 12 |
| STEPHEN J. KNIGHT | 1 | 3 |
| Ann Merrifield | 1 | 3 |
| Steve Gullans | 1 | 2 |
| Salvatore J. Salamone | 1 | 2 |
| Enrico J. Petrillo | 1 | 2 |
| AUGUSTINE J. LAWLOR | 1 | 2 |
| Gus Lawlor | 1 | 2 |
| Tara J. Butler | 1 | 2 |
| John J. Harris | 1 | 2 |
| RUDOLF J. GILMANSHIN | 1 | 1 |
| Frederick Blume | 1 | 1 |
| STEPHEN J. GULLANS | 1 | 1 |
| DAVID J. HOEY | 1 | 1 |
| JOHN J. CANEPA | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.